Furthermore, ESCC patients-derived xenografts containing high levels of pSTAT3 were sensitive to STAT3 inhibitors, whereas these expressed low levels of pSTAT3 were relatively resistant. Here, STAT3 is linked to esophageal squamous cell carcinoma.